INS and Insulin resistance: This positive impact of bezafibrate treatment upon glucose tolerance in rats treated with GC was associated with enhanced beta cell function (see insulin secretion in response to glucose along the GTT experiment in the BezaDexa group related to the Beza group) (Figure 4(c), n = 6–8) and the complete prevention of peripheral insulin resistance, as demonstrated in the insulin tolerance test (Figure 4(d), n = 6–8) and the estimation for the constant rate for glucose disappearance (KITT) (Figure 4(e), n = 6–8).